Suppr超能文献

通过不对称流场流分离评估熔融挤出制剂在水性介质中分散时纳米粒子的原位形成。

In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation.

机构信息

Drug Transport and Delivery Group, Department of Pharmacy, University of Tromsø, N-9037 Tromsø, Norway.

出版信息

J Pharm Biomed Anal. 2010 Nov 2;53(3):359-65. doi: 10.1016/j.jpba.2010.04.012. Epub 2010 Apr 24.

Abstract

In recent years melt extrudates (e.g. Meltrex) have proven to be a promising formulation tool for poorly water-soluble and poorly bioavailable drugs. During the hot-melt extrusion process solid dispersions are formed. For several of these formulations improved bioavailabilities have been reported; the mechanism behind, however is still not very well understood. The aim of this study was to investigate whether solid dispersions prepared by melt extrusion upon dispersion in aqueous medium form particles and/or supramolecular assemblies. The formulation investigated here contained the human immunodeficiency virus (HIV) protease inhibitors lopinavir and ritonavir, polyvinylpyrrolidone-vinyl acetate copolymer (Kollidon VA64), sorbitan monolaurate (Span((R)) 20) and hydrophilic fumed silica (Aerosil 200). The aqueous dispersions originating from both, API-containing and placebo formulation were investigated using photon correlation spectroscopy (PCS) and asymmetrical flow field-flow fractionation (AsFlFFF) with subsequent online multi-angle light-scattering (MALS) particle size analysis. The content of both APIs in the AsFlFFF-fractions was quantified using high performance liquid chromatography-mass spectrometry. PCS indicated sub-micron particles. AsFlFFF revealed the co-existence of up to three different types of colloidal to nanoparticulate assemblies in the aqueous dispersions. Even though a complete resolution of the composition of the sub-fractions could not be achieved, the following types could be clearly distinguished: The first fraction eluting from AsFlFFF, appears to be colloidal polymer. Only marginal amounts of the APIs were found associated with the polymer. Secondly, API-rich nanoparticles eluted. Thirdly, nanoparticulate assemblies assigned to sorbitan monolaurate and/or hydrophilic fumed silica were identified. A limited amount of drug was found associated with this fraction. Using AsFlFFF-MALS the size of particles in fractions could be determined. From this experience AsFlFFF is regarded as promising technique for investigation of particles/structures originating during dispersion of melt extrudates in aqueous medium in terms of size and type of nanoparticles and their API-content.

摘要

近年来,熔融挤出物(例如 Meltrex)已被证明是一种有前途的制剂工具,可用于制备水溶性差和生物利用度差的药物。在热熔挤出过程中形成固体分散体。对于其中的几种制剂,已经报道了改善的生物利用度;然而,其背后的机制仍不是很清楚。本研究的目的是研究通过熔融挤出制备的固体分散体在分散于水介质中时是否形成颗粒和/或超分子组装体。此处研究的配方包含人类免疫缺陷病毒(HIV)蛋白酶抑制剂洛匹那韦和利托那韦、聚乙烯吡咯烷酮-醋酸乙烯酯共聚物(Kollidon VA64)、山梨糖醇单月桂酸酯(Span((R)) 20)和亲水性气相法二氧化硅(Aerosil 200)。使用光子相关光谱法(PCS)和不对称流场流分离(AsFlFFF)以及随后的在线多角度光散射(MALS)颗粒尺寸分析,研究了来自含 API 和安慰剂配方的水性分散体。使用高效液相色谱-质谱法对 AsFlFFF 馏分中的两种 API 含量进行定量。PCS 表明存在亚微米颗粒。AsFlFFF 揭示了在水性分散体中存在高达三种不同类型的胶体至纳米颗粒组装体。尽管无法完全解析亚馏分的组成,但可以清楚地区分以下类型:首先从 AsFlFFF 洗脱的第一馏分似乎是胶体聚合物。只有少量 API 与聚合物相关。其次,富含 API 的纳米颗粒洗脱。第三,鉴定出与山梨糖醇单月桂酸酯和/或亲水性气相法二氧化硅相关的纳米颗粒组装体。发现药物的有限量与该馏分相关。使用 AsFlFFF-MALS 可以确定馏分中颗粒的大小。根据这一经验,AsFlFFF 被认为是一种有前途的技术,可用于研究熔融挤出物在水介质中分散时产生的颗粒/结构的大小和类型的纳米颗粒及其 API 含量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验